HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

FK 565

HCID 115204
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
79335-75-4
Standard SMILES
CCCCCCC(=O)N[C@H](CCC(=O)N[C@@H](CCC[C@@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)O)C(=O)O
InChIKey
ZRWBSKCFKHSDHD-LVQVYYBASA-N
Molecular formula
C22H38N4O9
Average molar mass
502.6 g/mol
Monoisotopic mass
502.2638788

Names & identifiers

Preferred name
FK 565
IUPAC
(2R,6S)-2-amino-7-[[(1R)-1-carboxyethyl]amino]-6-[[(4R)-4-carboxy-4-(heptanoylamino)butanoyl]amino]-7-oxoheptanoic acid
English name
FK 565
Molecular formula
C22H38N4O9
Molecular weight
502.56

Names & synonyms

FK-56579335-75-4FK 565HD9KDE59ZRDTXSID10229629D-Alanine, N-(1-oxoheptyl)-D-gamma-glutamyl-(6R)-6-carboxy-L-lysyl-RefChem:200962DTXCID10152120FR-41565N-(1-Oxoheptyl)-D-gamma-glutamyl-(6R)-6-carboxy-L-lysyl-D-alanineN-[(R)-6-Carboxy-N2-[N-(1-oxoheptyl)-D-gamma-glutamyl]-L-lysyl]-D-alanine(2R,6S)-2-amino-7-[[(1R)-1-carboxyethyl]amino]-6-[[(4R)-4-carboxy-4-(heptanoylamino)butanoyl]amino]-7-oxoheptanoic acid
Show more names
FR-53476Heptanoyl-α-D-glutamyl-(L)-meso-diaminopimelyl-(D)-alanineD-Alanine, N-(1-oxoheptyl)-D-γ-glutamyl-(6R)-6-carboxy-L-lysyl-N-(1-oxoheptyl)-D-γ-glutamyl-L-erythro-α,ε-diaminopimelyl-D-alanineN-[(R)-6-Carboxy-N2-[N-(1-oxoheptyl)-D-γ-glutamyl]-L-lysyl]-D-alanineN-[(6R)-6-Carboxy-N2-[N-(1-oxoheptyl)-D-γ-glutamyl]-L-lysyl]-D-alanine
(2R,6S)-2-Amino-6-((R)-4-carboxy-4-heptanamidobutanamido)-7-(((R)-1-carboxyethyl)amino)-7-oxoheptanoic acidFR 41565Heptanoyl-gamma-D-glutamyl-L-meso-diaminopimelyl-D-alanineN-[(R)-6-Carboxy-N2-[N-(1-oxoheptyl)-D-?-glutamyl]-L-lysyl]-D-alanineUNII-HD9KDE59ZRorb2945404SCHEMBL29440495YQF2723

Database identifiers

CAS
79335-75-4
PubChem CID
115204
DTXSID
DTXSID10229629
UNII
HD9KDE59ZR
Nikkaji
J227.678J

Properties

Computed structural propertiesFilling in

XLogP
-1.9
Topological polar surface area
225 Ų
Hydrogen bond donors
7
Hydrogen bond acceptors
10
Rotatable bonds
19
Heavy atoms
35
Formal charge
0
Complexity
744

Physicochemical properties

Boiling point
924.056 · 924.056±65.00 °C(Press: 760.00 Torr)(predicted)
Density
1.261 · 1.261±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka
2.513 · 2.513±0.24(predicted)
FDA UNII
9 KDE59ZR · HD9KDE59ZR
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 4 items

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Substances that inhibit the growth or reproduction of BACTERIA.

Applications · 1 item

UsesN-[(R)-6-Carboxy-N2-[N-(1-oxoheptyl)-D-γ-glutamyl]-L-lysyl]-D-alanine is an immunoactive peptide that can upregulate various genes associated with immune responses (apoptosis, inflammation, etc) in fetal vascular tissues. In addition, it also exhibits therapeutic properties for treating experimental and spontaneous metastases.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes